SKIPPER share price has zoomed 8% and is presently trading at Rs 541.4.
Meanwhile, the BSE CAPITAL GOODS index is at 68,097.8 (down 0.9%).
Among the top gainers in the BSE CAPITAL GOODS index today are V GUARD IND. (up 3.5%) and GMR Infra (up 1.7%).
ABB (down 3.9%) and BHEL (down 3.0%) are among the top losers today.
Over the last one year, SKIPPER has moved up from Rs 215.4 to Rs 541.4, registering a gain of Rs 326.0 (up 151.4%).
On the other hand, the BSE CAPITAL GOODS index has moved up from 46,119.3 to 68,097.8, registering a gain of 47.7% during the last 12 months.
The top gainers among the BSE CAPITAL GOODS index stocks during this same period were HINDUSTAN AERO. (up 129.8%), Siemens (up 105.6%) and Bharat Electronics (up 102.8%).
Don't Miss: Key Information for Long-term Investors
The BSE Sensex is at 80,187.6 .
The top losers among the BSE Sensex today are M&M (down 2.6%) and NTPC (down 2.2%). The most traded stocks in the BSE Sensex are Tata Steel and ITC.
In the meantime, NSE Nifty is at 24,455.7 (down 0.1%). M&M and NTPC are among the top losers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 64,571.9 to 80,187.6, registering a gain of 15,615.7 points (up 24.2%).
SKIPPER net profit grew 125.3% YoY to Rs 316 million for the quarter ended June 2024, compared to a profit of Rs 140 million a year ago. Net sales rose 96.9% to Rs 10,917 million during the period as against Rs 5,546 million in April-June 2023.
For the year ended March 2024, SKIPPER reported 129.6% increase in net profit to Rs 817 million compared to net profit of Rs 356 million during FY23. Revenue of the company grew 65.7% to Rs 32,820 million during FY24.
The current Price to earnings ratio of SKIPPER, based on rolling 12 month earnings, stands at 66.3.
Equitymaster requests your view! Post a comment on "SKIPPER Gains 8%; BSE CAPITAL GOODS Index Down 0.9%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!